The irony is, the main reason it is an underperforming asset, is because of Xinhe. They have been trying to strangle this company for years and deserve zero favours from anybody. Least of all the 95% of Bullseye shareholders who have made their opinions of them crystal clear for some time. There is no viable offer from Xinhe, and after talking to a few Bullseye shareholders, I get the impression they would rather 'swallow glass' than support anything these guys put forward.
The irony is, the main reason it is an underperforming asset, is...
Add EMR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.50 |
Change
0.010(0.29%) |
Mkt cap ! $2.293B | |||
| Open | High | Low | Value | Volume |
| $3.50 | $3.53 | $3.46 | $4.990M | 1.426M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15177 | $3.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.50 | 359949 | 2 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| EMR (ASX) Chart |